Neoadjuvant chemotherapy for osteosarcoma of the extremities: the Rizzoli Institute experience. 1990

G Bacci, and M Avella, and P Picci, and P Ruggieri, and R Biagini, and A Ferruzzi, and R Casadei, and P Caldora, and M Campanacci
Centro Tumori, Reparto di Chemioterapia, Università Istituto Ortopedico Rizzoli, Bologna, Italy.

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011182 Postoperative Care The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed) Care, Postoperative,Postoperative Procedures,Procedures, Postoperative,Postoperative Procedure,Procedure, Postoperative
D011300 Preoperative Care Care given during the period prior to undergoing surgery when psychological and physical preparations are made according to the special needs of the individual patient. This period spans the time between admission to the hospital to the time the surgery begins. (From Dictionary of Health Services Management, 2d ed) Care, Preoperative,Preoperative Procedure,Preoperative Procedures,Procedure, Preoperative,Procedures, Preoperative
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma

Related Publications

G Bacci, and M Avella, and P Picci, and P Ruggieri, and R Biagini, and A Ferruzzi, and R Casadei, and P Caldora, and M Campanacci
December 2008, Journal of pediatric hematology/oncology,
G Bacci, and M Avella, and P Picci, and P Ruggieri, and R Biagini, and A Ferruzzi, and R Casadei, and P Caldora, and M Campanacci
December 2005, European journal of cancer (Oxford, England : 1990),
G Bacci, and M Avella, and P Picci, and P Ruggieri, and R Biagini, and A Ferruzzi, and R Casadei, and P Caldora, and M Campanacci
November 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
G Bacci, and M Avella, and P Picci, and P Ruggieri, and R Biagini, and A Ferruzzi, and R Casadei, and P Caldora, and M Campanacci
February 2007, International journal of radiation oncology, biology, physics,
G Bacci, and M Avella, and P Picci, and P Ruggieri, and R Biagini, and A Ferruzzi, and R Casadei, and P Caldora, and M Campanacci
November 2002, European journal of cancer (Oxford, England : 1990),
G Bacci, and M Avella, and P Picci, and P Ruggieri, and R Biagini, and A Ferruzzi, and R Casadei, and P Caldora, and M Campanacci
June 2005, Cancer,
G Bacci, and M Avella, and P Picci, and P Ruggieri, and R Biagini, and A Ferruzzi, and R Casadei, and P Caldora, and M Campanacci
January 2002, Oncology reports,
G Bacci, and M Avella, and P Picci, and P Ruggieri, and R Biagini, and A Ferruzzi, and R Casadei, and P Caldora, and M Campanacci
July 2003, Annals of oncology : official journal of the European Society for Medical Oncology,
G Bacci, and M Avella, and P Picci, and P Ruggieri, and R Biagini, and A Ferruzzi, and R Casadei, and P Caldora, and M Campanacci
December 2006, Acta orthopaedica,
G Bacci, and M Avella, and P Picci, and P Ruggieri, and R Biagini, and A Ferruzzi, and R Casadei, and P Caldora, and M Campanacci
February 2001, Journal of chemotherapy (Florence, Italy),
Copied contents to your clipboard!